Tech Company Financing Transactions

Synosia Therapeutics Funding Round

Synosia Therapeutics, operating out of South San Francisco, raised $30 million in investment from 5AM Ventures, Abingworth and Novo Ventures.

Transaction Overview

Company Name
Synosia Therapeutics
Announced On
6/30/2006
Transaction Type
Venture Equity
Amount
$30,000,100
Round
Undisclosed
Investors

5AM Ventures (Andrew Schwab)

Abingworth (Andrew Sandham)

Novo Ventures (Heath Lukatch)

Versant Ventures (Bradley Bolzon)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
601 Gateway Boulevard 1200
South San Francisco, CA 94080
USA
Phone
(650) 244-4850
Website
www.synosis.com
Email Address
[email protected]
Overview
Synosia Therapeutics is a drug development company focused on finding innovative treatments for disorders of the central nervous system (CNS). We are leading a new approach in CNS, establishing a better understanding of a drug's action earlier in development than ever before through small, smart clinical trials.
Profile
Synosia Therapeutics LinkedIn Company Profile
Social Media
Synosia Therapeutics Company Twitter Account
Company News
Synosia Therapeutics News
Facebook
Synosia Therapeutics on Facebook
YouTube
Synosia Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Ian Massey
  Ian Massey LinkedIn Profile  Ian Massey Twitter Account  Ian Massey News  Ian Massey on Facebook
Chief Financial Officer
Philippe Lutz
  Philippe Lutz LinkedIn Profile  Philippe Lutz Twitter Account  Philippe Lutz News  Philippe Lutz on Facebook
Chief Medical Officer
Steve Bandak
  Steve Bandak LinkedIn Profile  Steve Bandak Twitter Account  Steve Bandak News  Steve Bandak on Facebook
Vice President
Lesley Pickford
  Lesley Pickford LinkedIn Profile  Lesley Pickford Twitter Account  Lesley Pickford News  Lesley Pickford on Facebook
VP - Bus. Development
Tom Woiwode
  Tom Woiwode LinkedIn Profile  Tom Woiwode Twitter Account  Tom Woiwode News  Tom Woiwode on Facebook
VP - Finance
Zachary Mcnealy
  Zachary Mcnealy LinkedIn Profile  Zachary Mcnealy Twitter Account  Zachary Mcnealy News  Zachary Mcnealy on Facebook
VP - Operations
Thomas Malefyt
  Thomas Malefyt LinkedIn Profile  Thomas Malefyt Twitter Account  Thomas Malefyt News  Thomas Malefyt on Facebook
VP - Operations
Ann Neale
  Ann Neale LinkedIn Profile  Ann Neale Twitter Account  Ann Neale News  Ann Neale on Facebook
VP - R & D
Uwe Meya
  Uwe Meya LinkedIn Profile  Uwe Meya Twitter Account  Uwe Meya News  Uwe Meya on Facebook
VP - Regulatory Affairs
Michael Elson
  Michael Elson LinkedIn Profile  Michael Elson Twitter Account  Michael Elson News  Michael Elson on Facebook

 

 

Browse more venture capital transactions:

Prev: 6/30/2006: Integrien venture capital transaction
Next: 6/30/2006: Solyndra venture capital transaction

 

Share this article

 

About Database of VC Transactions

We report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.